Introducton
Celiac disease (CD) is an autoimmune chronic T cell-mediated enteropathy, precipitated by gluten ingeston, that appears in genetcally predisposed individuals afectng, afectng around 1% of the general populaton. 1 The gluten-free diet (GFD) is the only treatment that efectvely relieves its symptoms, normalizes biochemical changes and the disease's intestnal mucosal damage. 1 Lifelong compliance with the GFD can be challenging for the patents due to its high economic cost, social restrictons and difcultes in complying with it. 2 For these reasons, in recent years, there has been growing interest in evaluatng a number of issues such as: whether the disease afects the patents' Quality of Life (QoL), if this is related to clinical presentaton characteristcs, if the treatment has a positve impact on these parameters or if mood disturbances, such as depression or anxiety, could infuence the QoL and compliance with the GFD. [3] [4] [5] [6] Given the evidence of an extremely wide variability range of CD symptoms, recent eforts have sought to clarify and unify clinical criteria. 2 Thus, clinical CD presentatons have been classifed into: Symptomatc (with intestnal and extraintestnal symptoms, also called classical CD) and subclinical (patents with or without the characteristc signs that occur below the threshold of clinical detecton). 2 It is to be expected, as confrmed by research, that clinical diferences correlate with psychological aspects and QoL, both before diagnosis and afer startng the GFD. 7 This chapter will explore existng scientfc knowledge about the relatonship between CD and QoL, psychological distress, depression and anxiety, as well as the implicatons and consequences entailed by a treatment based on the GFD.
Quality of Life
Health Related Quality of Life (HRQoL) expresses health status as perceived by the individual, in relaton to the disease itself and the efects that treatments have on the recipient; it is quite clear that this concept focuses on the patent's subjectve aspect. HRQoL measurement is a quanttatve assessment of the health status and it includes not only physical but also emotonal and social aspects. Such measurement has become mandatory in the analysis of the efectveness of the treatments employed and the evoluton of specifc conditons, especially in chronic diseases. HRQoL analysis is based on a multdimensional concept, which includes assessment of the patent's psychological well-being, emotonal state, physical and social functoning and general health percepton. [3] [4] [5] [6] Regarding gastrointestnal diseases, the most important aspects include the percepton of gastrointestnal symptoms relief and the benefts it may bring to the functonal status and general well-being. 4 HRQoL can be measured by a variety of instruments, both general and disease-specifc questonnaires. General questonnaires cover a wide spectrum of domains and allow comparison between diferent diseases and populatons, whereas disease-specifc questonnaires for each focus on partcular aspects of it and its treatment and are more sensitve in detectng small changes in the QoL. 6 Most studies assessing QoL in CD patents used general questonnaires that focus on generic items developed for chronic diseases. The most frequently used are: Short Form Health Survey (SF-36), the Psychological General Well-being (PGWB) index, EuroQuol-5D questonnaire (EQ) and the Gastrointestnal Quality of Life Index (GIQLI). [3] [4] [5] [6] The SF-36 measures functonal status and wellbeing and it includes eight items divided into three categories: physical health status, mental status, and a combinaton of both which includes vitality and general health. 4, 9, 11 GIQLI is a selfadministered questonnaire designed to assess QoL in patents with gastrointestnal diseases. 5 EQ is a self-administered questonnaire with a descriptve profle along with a QoL index. It covers fve areas: mobility, self-care, daily actvites, pain and anxiety-depression. 5, 7, 9 PGWB is a validated and reliable questonnaire which allows evaluatng the patent's distress and mental state. 10 In recent years CD-specifc questonnaires have been introduced both for pediatric and adults populatons but, unfortunately, evidence for their efcacy is stll limited. Since the beginning, the investgatons focused on the analysis of CD patents' QoL, it was believed that QoL was signifcantly reduced before diagnosis. Later studies with an adequate clinical characterizaton, revealed and confrmed the impression that, before diagnosis, patents with actve disease and classical gastrointestnal symptoms show a marked decrease in QoL when compared with the general populaton. 4, 7, 9 In this context, prospectve studies have shown that symptomatc celiac patents submited QoL diagnostc scores similar to those of patents with chronic disabling disorders such as those cerebrovascular accidents. 7 A limited number of studies have shown that individuals diagnosed with CD as a consequence of screening in populatons at high risk for the disease have a beter QoL than patents diagnosed on the basis of symptoms 8, [12] [13] [14] [15] ( Figure 1 ). It is noteworthy that the vast majority of those surveyed who turned out to have CD, corresponded to the subclinical group. The longitudinal study made by Nachman et al 12 , with a four-year follow-up afer diagnosis, showed that surveyed patents had QoL scores similar to those of the general populaton without signifcant changes from the baseline. A recent study by Rosén et al. 17 evaluated QoL in adolescents diagnosed by screening in a high-risk populaton. In this study, it was observed that, despite the fact that this populaton was characterized as subclinical, not all patents saw themselves as healthy and that the CD diagnosis, along with its treatment, represented a beneft to their health. However, a subgroup saw the illness as a stgma that limited their daily lives which, especially in the social feld, was more pronounced in the female gender.
In general, these studies suggest that the onset of the GFD implies an improvement in the QoL which, for some authors, produces similar long-term scores to those of the general populaton. 8 However, other authors suggest that QoL improvement due to the GFD does not come close to the general populaton's percepton. 6, 11 A quick assessment of these disparites regarding response to the GFD suggests it could be due to cultural diferences between the populatons involved; however, the most notable diferences seem to lie in the type of research design. Thus, most of the research studies use a crossover design which evaluates diferent populatons both at the tme of diagnosis and afer treatment; this methodological aspect diminishes the conclusions' value. The few studies which had a prospectve and longitudinal design suggest that GFD has a signifcant impact on the QoL of patents. Moreover, some studies reported a positve GFD impact regarding the QoL, both in its classical and subclinical forms. Thus Ciacci et al. 27 found that 84% of the patents improved their QoL percepton afer initatng the GFD. Casellas et al., 5 who evaluated the QoL using the GIQLI and EQ questonnaires before treatment and afer the GFD, found that diminished values in both pre-treatment questonnaires improved signifcantly afer GFD and that they were similar to those of the general populaton. Finally, Nachman et al. 8 confrmed these observatons and showed that the positve impact of the GFD was more signifcant in the frst three months afer startng specifc treatment (Figure 1 ). The QoL scores afer one year of GFD were comparable to those of the general populaton, regardless of clinical severity of the diagnosis or the degree GFD compliance (Figure 1) . Interestngly, the contnuaton of this longitudinal study showed a deterioraton in the SF-36 items afer 4 years of treatment ( Figure 2 ). The most remarkable point regarding this observaton is that patents who adhered strictly to the GFD had a similar QoL to that of controls. Conversely, partally compliant patents had a signifcant deterioraton of the QoL (Figure 3 ). 12 An interestng fnding of this study was that patents with less severe symptoms at the tme of diagnosis had a decrease in QoL indexes afer four years of GFD regardless of the degree of compliance to the later. The authors postulate that this efect might be due to the burden such a restrictve diet would imply in relaton to low disease percepton. 12 Most observatons suggest that female CD patents ofen have greater QoL impairment than men, both at the tme of diagnosis and afer treatment, even with strict GFD compliance. These fndings are mainly observed in the diferent mental domains of the questonnaires. 3, 5, 6, 9, 11 It has been proposed that this phenomenon may be due to the higher prevalence of anxiety in women. 6 The presence of clinical symptoms and a decrease in the QoL could be related to the existence of a second undetected disorder, ofen irritable bowel syndrome, pancreatc insufciency, bacterial overgrowth or microscopic colits. Summing up this secton, patents with CD have a lower QoL than the general populaton. Evidence suggests that this involvement is important in symptomatc patents, especially those with classic symptoms. By contrast, the few studies on (usually subclinical) patents diagnosed by screening concur on the fact that these patents have no QoL decline. The GFD produces rapid improvement of all QoL aspects in symptomatc CD patents. The response of subclinical patents to treatment would seem to be of litle signifcance. 
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Figure 2. Quality of life reported by SF-36 questonnaires in a general populaton of celiac disease patents evaluated at the tme of diagnosis, at one and at four years afer startng treatment. The score increase afer one year means an improvement in the evaluated parameters. A deterioraton is observed in most parameters afer four years.
Celiac Disease and Psychological Disorders
Addressing the issue of psychological distress in CD is, at frst glance, very interestng but ofen difcult to understand. A multplicity of studies have focused on its evaluaton, especially during the last decade, with dissimilar and even contradictory results. Since the frst descriptons of the disease, references were made to psychological symptoms and disorders, albeit in a vague fashion which was not consistent with a specifc conditon. Thus, for example, these descriptons spoke of a "weariness" which was considered to be psychic in origin, since it which persisted even when the patent had improved clinically. 18 Behavior characterized by "tantrums, irritability and a negatve attude" was described, in 1950, in a group of children who changed dramatcally immediately afer startng the GFD, while, in adults, a "syndrome of insomnia, depression and headache" was described. 19 Throughout the disease's short history, celiac patents have been characterized as mentally peculiar, nervous, unstable, depressed and even as schizophrenic. 20, 21 By 1970, D. Goldberg 22 performed the frst standardized assessment of a series of a group of patents on a GFD and found a high prevalence of depressive traits that showed no relaton either with gastrointestnal symptoms or nutritonal status. Afer one-year follow-up, the same author found no schizophrenic patents among those evaluated (a disease that had been previously reported by Dohan 21 ) and noted that those individuals who remained sick ofen had a family history of psychiatric illness. He concluded that signs of depression, common in celiac patents, were possibly related to genetc factors. Subsequently, other authors also found a higher prevalence of psychiatric history prior to CD diagnosis, depression being the most frequently associated psychic disorder. 23 Furthermore, anxiety disorders (diagnostc reactve anxiety state, social phobia and panic disorder) have also been associated with CD but, in this case, without conclusive evidence.
Anxiety
While high levels of nonspecifc anxiety have been reported in celiac patents, this does not appear to be a stable personality trait, but a state reactve to diagnosis or secondary to symptoms. A study by Addolorato et al. 24 seems to suggest this. These authors assessed anxiety and depression using the Hamilton State-Trait Anxiety scale and the Zung Self-Ratng Depression Scale, respectvely. They found that anxiety reversed in the following year. A signifcantly higher number of patents with panic disorder and depression has also been reported but generally associated with a third very common CD medical conditon, autoimmune thyroidits. Therefore, the authors propose a possible causal associaton. 25 Social phobia, another anxiety disorder, has been associated with CD, as well as specifc or generalized forms, present both in newly diagnosed patents and in those who were already complying with the GFD. 26 As expected, a signifcantly higher percentage of associated depression was also observed. This could be considered to be consistent with the fndings of C. Ciacci et al., 27 who described more problems in social life and anxiety related to feeling diferent from the general populaton in patents diagnosed afer the age of 20, even in cases with good diet compliance. Interestngly, this cross-sectonal study of unrelated populatons detected no diferences between newly diagnosed patents compared with those who were complying with the GFD. 27 Unlike previous evidence, a study performed in Germany suggested an increased risk of a probable anxiety disorder (but not depression) restricted to celiac women complying with GFD when compared to the general populaton. 28 It is striking, in this study, that the risk was lower among patents who lived alone. Again, we face the queston of the weight of social factors and it could be thought that, for some women with celiac disease who adhere to the GFD, the social environment may be experienced more as a burden than as helpful. A 10-year follow-up study by Hallert et al., 29 which evaluated the burden of the disease in terms of concerns, restrictons and personal balance, showed that women expressed more concern about its impact on relatonships with friends and about having to abstain from the "important things" in life. Finally, a recent meta-analysis based on a review of 11 selected studies which evaluated the strength of the associaton between anxiety and CD, concluded that adults with celiac disease do not difer, in terms of anxiety levels, from the general populaton or from people with other chronic diseases. 30 To sum up, anxiety seems to be present in CD patents, not as a characteristc of the disease itself, but possibly as reacton to the diagnosis or the difcultes associated with complying with the diet and its social impact. In this sense, we believe that the diagnosis of an adjustment disorder with an anxiety state, should be considered at least in a group of patents.
Depression
Depression is the psychic disorder to which earliest reference is made and the most studied in relaton to CD. Here the term is used in its broadest sense without discriminatng its diferent clinical forms, as published studies have used a variety of assessment tools, which do not allow an accurate transpositon of their results. In 1982, Hallert and Derefeldt 23 reported similar fndings in an area of Sweden with a high prevalence of CD, they reported that 21% of the patents had received psychiatric care prior to diagnosis, depression being the most common fnding. In a subsequent study, Hallert and Aström 31 found signifcantly higher levels in scale 2 of the Depression Minnesota Multphasic Personality Inventory-2 compared with a control group of surgical patents. Interestngly, this result did not correlate signifcantly with abdominal symptoms and these authors described a characteristc depressive mood in patents, diferent from other medical conditons, such as colits. This led them to consider depressive psychopathology as a feature of adults with CD, suggestng that this is possibly a consequence of malabsorpton, a hypothesis which will be discussed later. In a study by Vaitl and StouthamerGeisel, who evaluated a cohort of 182 CD patents using a self-administered questonnaire (Symptom Check List Revised (SCL 90-R)), observed that a signifcant proporton of the patents had a history of psychological symptoms for which they had received drug treatment (32%) and/or psychotherapy (14%). These authors concluded that celiac patents had a "psychovegetatve" state of exhauston with a distnct depressive component. 32 Research studies carried out in Italy in 1998 transversely evaluated depression in adult CD patents compared with healthy individuals and patents with persistent chronic hepatts. 33 Using a modifed version of the Zung Self-Ratng Depression Scale, they concluded that depressive symptoms are characteristc of celiac patents, independently of the tme of diagnosis and GFD compliance. Despite these limitatons in establishing these new conclusions, these authors identfed three main characteristcs associated with CD: reactvity, pessimism, asthenia and anhedonia. Also Addolorato et al. 24 found that a large number of patents had depression, and that this was maintained without signifcant changes afer one year with a GFD. The authors proposed that this depression may be related to a reducton in QoL. Recently, two longitudinal and prospectve studies by Nachman et al. 8, 12 which evaluated QoL and depression at the tme of diagnosis and afer four years' follow-up, showed high percentages of inital depression, especially in patents with classic symptomatc clinical course (gastrointestnal symptoms). This conditon improved dramatcally afer a year with the GFD, and deteriorated slightly during the four-year evaluaton, without revertng to the inital pathological levels (Figure 4) . The authors found an inverse relatonship between depressive symptoms and adherence to the diet ( Figure  5 ). Similarly, Finnish authors detected an inital improvement in QoL in a group with a GFD afer a year of treatment; however, QoL evaluated eight years afer diagnosis worsened in relaton to the control group. Despite diferences in research regarding the populatons involved materials, the methodology applied to the investgatons and results that preclude comparison between studies, we can say that there is enough consensus in that depression occurs with greater frequency and severity among celiac patents than in the general populaton. Additonally, a very large populaton study in Sweden found a statstcally signifcant associaton between CD and depression, which seems to leave no room for doubt 34 . Finally, a recent meta-analysis published by Smith and Gerdes 30 came to a similar conclusion reviewing 18 diferent published studies. These authors concluded that more than 8,000 new negatve reports would be required for the associaton if these results were to be denied. However, there is no agreement in the literature regarding the efects that the GFD has on these symptoms, having reported improvements in some studies 8, 12, 36, 37 but not in others. 24, 33 Summing up, depression is demonstrably associated with CD and its evaluaton should be part of the diagnosis. It is important to consider that depression can adversely afect the course of the disease by decreasing the motvaton and energy to comply with the diet, having a negatve impact on interpersonal relatonships including the doctor-patent relatonship and inducing a negatve evaluaton of treatment outcomes by the patent. 51 Depressed people are three tmes more likely not to comply with treatment than those who are not.
52
Regarding the efects the GFD has on depression, it is stll premature to draw conclusions given the diferences shown by this research. Surely the assessment of advantages and disadvantages of treatment is one of the future lines of enquiry. Finally, an interestng feld arises today regarding absorpton-related factors and immune processes, especially infammatory processes related to the gut-brain connecton. 32 
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Figure 4. Depression level progression at the tme of diagnosis and during long-term monitoring (one to four years) as measured by the Beck Depression Index (BDI) in a series of CD patents.
Research on the Pathophysiology of Depression
From the pathophysiological point of view, depression is a complex and multfactorial conditon generated by several kinds of factors, including, among others: Biological, such as nutritonal (linked to malabsorpton and its consequences), genetc, immunological and endocrinological. 25, 43 In additon, one must consider the psychological and environmental factors since CD is a chronic disease 51 where sufering can be generated by the symptoms and the inconvenience of having to follow a lifelong restrictve diet. Nutrient malabsorpton could be the mediatng mechanism between CD and depression by interfering with the producton of key neurotransmiters for mood regulaton, in partcular, defciencies relatve to tryptophan malabsorpton, necessary for the producton of serotonin, a key neurotransmiter for mood regulaton. 35 Hallert et al. 36 determined metabolite concentratons of the three major monoamines in cerebrospinal fuid in a short series of patents and found a signifcant reducton in the levels of 5-hydroxy-indole acetc, homovanillic acid and 3-methoxy-4-hydroxy feniletlenglicol (MOPEG), all of them indicatve of a reducton in the central metabolism of the three monoamines (serotonin, dopamine and norepinephrine). Their concentratons, partcularly those of MOPEG, inversely correlated with depressive symptoms. In a subsequent study, the same authors explored monoamine concentratons in patents treated with a GFD. 37 This study suggested that the low level of the same could be related to poor intestnal absorpton. Monoamine synthesis is regulated, among other dietary components, by vitamin B6, which is generally malabsorbed by celiac patents. The same Scandinavian group followed up celiac patents diagnosed with depression who had not improved afer one year despite the GFD having normalized their mucosal intestnal damage. 38 When they were reassessed three years later and afer receiving vitamin B6 orally (80 mg/day of pyridoxine), they observed a signifcant decrease in depressive symptoms. In a multcenter, double-blind study on patents who followed a strict GFD and took daily vitamin B supplementaton, normalizaton of plasma homocysteine levels (marker of B vitamin status) was 399 
12
DBI demonstrated, which correlated with the improvement of the general welfare and signifcant decrease in anxiety and depression. 39 Other malabsorpton efects can cause symptoms that are confused with and/or overlap with depression. Folic acid defciency can cause fatgue, apathy, and impaired memory. Iron defciency, with or without anemia, can cause tredness and easy fatgue. In this regard, an Italian study more recently assessed the prevalence, characteristcs and associatons of chronic fatgue and depression. 40 The results showed that fatgue is a feature of CD which improves litle with the GFD. These authors suggested that fatgue may have a cognitve and afectve origin and that it would tend to decrease in treated patents, while depression would remain or even worsened.
CD is associated with other autoimmune endocrine diseases such as type I diabetes mellitus and Hashimoto's thyroidits, both with increased risk of depression. 41, 42 Carta et al. 25 found a high prevalence of panic and depression disorders in those celiac patents with positve antthyroid antbodies. They suggested that the associaton with subclinical thyroidits could represent a signifcant risk factor for these psychiatric disorders. Garud et al. 43 studied the prevalence of psychiatric and autoimmune disorders in CD, fnding that the risk of depression was the same as that of the general populaton, but that it became higher when associated with DM1, doubling the percentage of patents with clinical depression.
Celiac Disease and the Emotonal Realm
The psycho-emotonal component of CD cannot be dismissed given that psychological distress and social and emotonal adaptaton to the disease and its treatment surely play an important role. Depression can develop as a result of the discomfort produced by symptoms of the disease, even in the very frequent cases in which the patent doesn't receive an inital diagnosis and wanders from one doctor to another for years, without fnding an answer to his or her conditon. Again we fnd some contradictory results, since at least in two studies depression did not correlate with the presence of somatc symptoms. 11, 28 However, Nachman et al. 8 while evaluatng a cohort of patents at the tme of diagnosis using the Beck Depression Inventory (BDI), found a high prevalence of moderate and/or severe depression in patents with symptomatc classical clinical presentaton, but with values equal to the general populaton in subclinical cases. In a recent epidemiological study conducted in Canada, the annual prevalence of major depressive disorders in people with one or more diseases was 9.2% compared with 4.0% in those who reported no other conditon. 44 In this study, major depression in people with bowel disorders, Crohn's disease and colits was of 16.4%, fndings similar to those of other investgatons. 45, 46 All chronic diseases have a strong impact on the QoL. One of the major changes, perhaps generatng further deterioraton, is the emotonal aspect, since the person is necessarily forced to undergo a rapid adaptaton process, which passes through diferent stages, which evoke a range of usually negatve emotons (fear, anger, anxiety). In the case of CD, it may appear that the balance of the necessary dietary changes with a view to their intended is highly positve. In this sense, it should not be very difcult to accept the disease and certainly benefts, this happens ofen. However, adaptaton to GFD is more difcult than it seems upon frst impression. Patents must make permanent changes to important aspects of their life and regarding self-control, for which they need knowledge, skills and discipline. Considering these difcultes, it is not surprising that a signifcant number of patents develop psychosocial problems. Linking all these factors, an Italian study evaluated the impact of a chronic disease in relaton to CD's psychiatric symptoms, the degree of acceptance of the disease and the impact that the diet has on QoL. 4 The results showed signifcantly high anxiety levels and depression in the celiac group and in the diabetc group compared with healthy controls. Furthermore, the duraton of the gluten restricton correlated with signifcantly depression higher levels in newly diagnosed patents. The authors concluded that frequent afectve disorders in celiac patents are linked to the fact that it is a chronic disease and to difcultes in adjustng to the diet, and should not be considered disease traits in themselves.
Diet restrictons have a bigger infuence on the style of life of celiac patents than what it was previously thought since they strongly interfere in daily actvites and social life. A survey of celiac patents (74% women) showed several areas where maintaining a GFD has a negatve impact in situatons such as eatng out with the family, travelling and at work. 48 An interestng Swedish study dealt with situatons which ofen lead to confusion and discomfort in relaton to the disease causing conficts (dilemmas) to celiac people with a GFD. 49 The results indicated that they afect diferent areas: the emotonal area, interpersonal relatonships and celiac patent's daily actvites in diferent setngs: at work, shopping, travelling, and eatng out and at home. The predominant feelings were: isolaton, shame, fear of gluten contaminaton and concern over being troublesome. In interpersonal relatonships, situatons like being forgoten or neglected, not wantng to draw atenton because of the disease and to avoid talking about the subject or lowering their guard so as to avoid being exposed. Finally, daily life complicatons are related to the lesser availability of gluten-free products, increased efort and to being constantly vigilant and alert. However, despite the above, many patents with chronic diseases do not show high levels of distress, which raises the queston of which may be the protectve factors. Many studies have shown the importance of considering the individual characteristcs and coping skills of patents as central factors. The way in which a patent responds to problems can be become a favorable or negatve point for our physical and mental wellbeing. In this regard, the presence of a specifc celiac psychological profle has been suggested. 50 Its main characteristcs would be high irritability accompanied by high psychophysiological reactvity and a kind of conformity that refects both the difculty in expressing feelings as much as the desire to have a good image in front of others. The authors proposed that this increased psychophysiological reactvity could be related to the worry and the weight of shouldering a chronic disease, as well as with hyper vigilance in relaton to food. The trend towards a conforming behavior may be related to avoidance of situatons with greater exposure consistent with a lifestyle limited by the presence of a chronic disease.
Conclusions and Recommendatons
In recent years, the QoL concept in relaton to CD has become relevant. Classic CD patents prior to diagnosis showed a low QoL, which experience a signifcant improvement by the GFD. In contrast, the situaton in patents with subclinical CD is not as clear. Depression is more prevalent and more severe in celiac patents than in the general populaton. We do not know if there is a major etopathogenic factor that accounts for it; however, it is more appropriate to think in the synergy of several factors that possibly interact in varying proportons. On the other hand, there is no such certainty regarding anxiety disorders. In any case, it is necessary to take into account the need to assess the presence of both disorders at the tme of diagnosis, especially depression. This recommendaton is related to the proven associaton that this mental disorder has on the development, adherence and response to treatments, as has been observed in various chronic diseases. Its evaluaton during primary care consultatons can be done by means of simple questons and from there it can be decided whether the case is suitable for psychiatric or psychological referral. 
